Terazosin
NDC 70518-0074, Terazosin Hydrochloride, capsule, from REMEDYREPACK INC..
- Product NDC
- 70518-0074
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075317
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-0074-1 | 70518007401 | 30 CAPSULE in 1 BLISTER PACK (70518-0074-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a3a5901a-6395-4030-a27b-1fb17cd97315
Use it
Look up 70518-0074 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-0074. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.